EDITORIAL
Published on 06 Sep 2021
Editorial: CD4+ T Cells in Cancer Immunotherapies
doi 10.3389/fimmu.2021.737615
- 2,157 views
- 4 citations
- Frontiers in Immunology
- T Cell Biology
- Research Topics
- CD4+ T Cells in Cancer Immunotherapies
CD4+ T Cells in Cancer Immunotherapies
24k
Total downloads
87k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 05 Jul 2021
A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells
doi 10.3389/fimmu.2021.703632
- 4,900 views
- 8 citations
REVIEW
Published on 28 Jun 2021
Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
doi 10.3389/fimmu.2021.669992
- 5,570 views
- 24 citations
REVIEW
Published on 03 May 2021
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
doi 10.3389/fimmu.2021.669474
- 22,396 views
- 181 citations
REVIEW
Published on 12 Mar 2021
The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy
doi 10.3389/fimmu.2021.625667
- 13,778 views
- 61 citations
REVIEW
Published on 26 Feb 2021
The Impact of Tregs on the Anticancer Immunity and the Efficacy of Immune Checkpoint Inhibitor Therapies
doi 10.3389/fimmu.2021.625783
- 6,740 views
- 51 citations
REVIEW
Published on 23 Feb 2021
PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy
doi 10.3389/fimmu.2021.636238
- 12,682 views
- 35 citations
REVIEW
Published on 30 Nov 2020
Systemic CD4 Immunity as a Key Contributor to PD-L1/PD-1 Blockade Immunotherapy Efficacy
doi 10.3389/fimmu.2020.586907
- 8,447 views
- 51 citations
Published in
Frontiers in Immunology
- T Cell Biology
Impact
- 87kTopic views
- 61kArticle views
- 24kArticle downloads